# Victoire Laurenty

> Victoire Laurenty is a Series A investor at Kerala Ventures backing Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Kerala Ventures](https://shizune.co/investors/profile/kerala-ventures)
- Location: Paris, France
- Total investments: 2
- Last investment: Dec 2024
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/victoirelaurenty

Victoire Laurenty is a Series A investor at Kerala Ventures in Paris focused on Biotechnology and Pharmaceutical. Victoire joined Kerala to lead dealflow operations after starting her career in strategy consulting at L.E.K. Consulting (3y) and in the Ardian Growth investment team (1,5y).At L.E.K. she executed numerous strategic due diligences for various private equity funds and several corporate strategy assignments.At Ardian Growth, Victoire hasparticipated to more than 5 deals and reinvestments in the digital and IT sector including Planiware, Clever Age, TabMo and Uptoo.Victoire graduated from Telecom Paristech, and holds a MSc in Applied Mathematics from the London School of Economics.Past and current Boards: Ouihelp

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 1 | 50% |
| Pharmaceutical | 1 | 50% |
| Machine Learning | 1 | 50% |
| Quantum Computing | 1 | 50% |
| Artificial Intelligence | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AQEMIA | AQEMIA is a pharmatech company developing a drug discovery platform to discover new drugs for specific therapeutic targets. Its platform combines quantum-inspired physics and machine learning to scale the drug discovery process, generating a growing pipeline of new drug candidates. The company utilizes advanced techniques, including generative AIand atomic scale physics, to design novel drugs tailored for specific therapeutic targets. | $38M | Series A | Dec 10, 2024 |  |
| AQEMIA | AQEMIA is a pharmatech company developing a drug discovery platform to discover new drugs for specific therapeutic targets. Its platform combines quantum-inspired physics and machine learning to scale the drug discovery process, generating a growing pipeline of new drug candidates. The company utilizes advanced techniques, including generative AIand atomic scale physics, to design novel drugs tailored for specific therapeutic targets. | $32.5M | Series A | Jan 30, 2024 |  |

2 of 2 investments shown.

## Co-investors
- [Eurazeo](https://shizune.co/investors/profile/eurazeo-com) — VC Fund, 3 deals together
- [Elaia](https://shizune.co/investors/profile/elaia-partners) — VC Fund, 2 deals together
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 1 deal together
- [Bpifrance Large Venture](https://shizune.co/investors/profile/bpifrance-large-venture-81e4) — VC Fund, 1 deal together
- [Cathay Innovation](https://shizune.co/investors/profile/cathay-innovation-fund) — VC Fund, 1 deal together
- [Cathay Innovation](https://shizune.co/investors/profile/c-entrepreneurs) — VC Fund, 1 deal together

## About Kerala Ventures

VC Fund · Paris, France

Kerala Ventures is a VC firm investing in early-stage tech startups (SaaS, marketplaces, AI, data, tech-enabled services …) based in France.Their first investment ranges from €100K to €1.5M and their portfolio includes 10 companies (+ 1 successful exit).They are insanely focused on creating a unique value proposition for early-stage founders:- A strong operational support on hiring (93 recruitments for their portfolio since 2015 thanks to their private hiring network first20.club)- Actionable expertise in supporting growth (Doctolib, Lafourchette, Evaneos, ...) with hundreds of employees & tens of millions of Euros of revenue- Hands-on approach thanks to their operational background & their personal financial commitment in the deals they make

5 contacts available at Kerala Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Antoine Freysz | Founding Partner | https://shizune.co/investors/profile/antoine-freysz |
| Marc Laurent | Founding Partner | https://shizune.co/investors/profile/marc-laurent |
| Olivier Occelli | Founding Partner | https://shizune.co/investors/profile/olivier-occelli |
| Thomas Thimothee | Partner and CTO | https://shizune.co/investors/profile/thomas-thimothee |
| Victoire Laurenty | Associate | https://shizune.co/investors/profile/victoire-laurenty |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Victoire Laurenty invest in?

Victoire Laurenty invests primarily in Biotechnology, Pharmaceutical and Machine Learning startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Victoire Laurenty last invest?

The most recent investment recorded for Victoire Laurenty closed in Dec 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co